Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial-Reference-Cited by-同舟云学术

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

Published:2013-03 Issue:9870 Volume:381 Page:918-929
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Smolen Josef S,Nash Peter,Durez Patrick,Hall Stephen,Ilivanova Elena,Irazoque-Palazuelos Fedra,Miranda Pedro,Park Min-Chan,Pavelka Karel,Pedersen Ronald,Szumski Annette,Hammond Constance,Koenig Andrew S,Vlahos Bonnie

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis;Welsing;Arthritis Rheum,2001

2. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time;Drossaers-Bakker;Arthritis Rheum,1999

3. Measuring function in rheumatoid arthritis: identifying reversible and irreversible components;Aletaha;Arthritis Rheum,2006

4. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade;Smolen;Ann Rheum Dis,2009

5. Treating rheumatoid arthritis to target: recommendations of an international task force;Smolen;Ann Rheum Dis,2010

Cited by 306 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis;Expert Opinion on Biological Therapy;2024-07-25

2. Impact of concomitant methotrexate on disease activity in patients with rheumatoid arthritis tapering abatacept: results from KOBIO registry;Frontiers in Medicine;2024-07-22

3. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide;Reumatología Clínica;2024-07

4. Prevalence and Factors Associated with De-escalation of Anti-TNFs in Older Adults with Rheumatoid Arthritis: A Medicare Claims-Based Observational Study;Drugs & Aging;2024-06-20

5. Disease activity–guided dose optimization including discontinuation of TNF inhibitors in rheumatoid arthritis is effective for up to 10 years: an observational follow-up of the DRESS study;Rheumatology;2024-02-12